These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5001883)

  • 41. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 42. Tuberculosis in Tanzania: a national sampling survey of drug resistance and other factors.
    Tubercle; 1975 Dec; 56(4):269-94. PubMed ID: 59442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.
    McLaughlin AM; Gibbons N; Fitzgibbon M; Power JT; Foley SC; Hayes JP; Rogers T; Keane J
    Am J Respir Crit Care Med; 2012 Jul; 186(1):110-1. PubMed ID: 22753693
    [No Abstract]   [Full Text] [Related]  

  • 44. The tuberculosis pandemic--which way now?
    Zumla A; Mwaba P; Squire SB; Grange JM
    J Infect; 1999 Mar; 38(2):74-9. PubMed ID: 10342645
    [No Abstract]   [Full Text] [Related]  

  • 45. Isoniazid preventive therapy and risk for resistant tuberculosis.
    Balcells ME; Thomas SL; Godfrey-Faussett P; Grant AD
    Emerg Infect Dis; 2006 May; 12(5):744-51. PubMed ID: 16704830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Consensus: management of tuberculin-positive children without evidence of disease.
    Grossman M; Hopewell PC; Jacobs RF; Kendig EL; Smith MH
    Pediatr Infect Dis J; 1988 Apr; 7(4):243-6. PubMed ID: 3130606
    [No Abstract]   [Full Text] [Related]  

  • 47. [Rifampicine in tuberculosis. Peculiarity of its experimental activity and new therapeutic prospects].
    Le Lirzin M; Grumbach F
    Pathol Biol (Paris); 1972 Oct; 20(19):785-92. PubMed ID: 4628424
    [No Abstract]   [Full Text] [Related]  

  • 48. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tuberculosis: the new challenge to the practicing clinician.
    Sbarbaro JA
    Chest; 1975 Sep; 68(3 Suppl):436-43. PubMed ID: 808400
    [No Abstract]   [Full Text] [Related]  

  • 50. Unveiling a tuberculosis drug target.
    Travis J
    Science; 1994 Jan; 263(5144):172. PubMed ID: 8284668
    [No Abstract]   [Full Text] [Related]  

  • 51. [Mycobacterial resistance in Lower Franconia].
    Seeliger HP; Weicksel P; Ahiaku-Brew C
    Prax Pneumol; 1970 Mar; 24(3):180-8. PubMed ID: 4985391
    [No Abstract]   [Full Text] [Related]  

  • 52. [Contributions on the biological properties of Mycobacterium tuberculosis on the basis of the sensitivity of lupus strains].
    Simon N; Berencsi G
    Arch Klin Exp Dermatol; 1966 Jun; 225(2):123-35. PubMed ID: 4966444
    [No Abstract]   [Full Text] [Related]  

  • 53. Persistence, not resistance, is the cause of loss of isoniazid effect.
    Wallis RS; Palaci M; Eisenach K
    J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
    [No Abstract]   [Full Text] [Related]  

  • 54. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
    Belogurova VP; Gorislavets II; Ivanitskaia NN
    Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
    [No Abstract]   [Full Text] [Related]  

  • 55. Primary resistance to the major drugs in tuberculous patients, in 1961-1966.
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Pol Med J; 1969; 8(5):1131-5. PubMed ID: 4986628
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug resistance trends in Mycobacterium tuberculosis: Blackburn 1985-89.
    Ormerod LP; Harrison JM; Wright PA
    Tubercle; 1990 Dec; 71(4):283-5. PubMed ID: 2125155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Limits in tuberculosis chemotherapy as revealed by experimental study in mice.
    Kanai K; Kondo E
    Jpn J Med Sci Biol; 1971 Oct; 24(5):313-21. PubMed ID: 5003823
    [No Abstract]   [Full Text] [Related]  

  • 58. [Modern chemotherapy of tuberculosis].
    Unholtz K
    Munch Med Wochenschr; 1970 May; 112(21):1003-11. PubMed ID: 5467739
    [No Abstract]   [Full Text] [Related]  

  • 59. [Causes of the alleged isoniazid failure in the therapy of skin tuberculosis].
    Meyer-Rohn J
    Hautarzt; 1968 Mar; 19(3):124-6. PubMed ID: 4972123
    [No Abstract]   [Full Text] [Related]  

  • 60. Presence of katG gene in resistant Mycobacterium tuberculosis.
    Jaber M; Rattan A; Kumar R
    J Clin Pathol; 1996 Nov; 49(11):945-7. PubMed ID: 8944618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.